Session Details
[2AT2-10]8. Biology of Diseases Ⅴ
Wed. Dec 2, 2026 11:15 AM - 12:45 PM JST
Wed. Dec 2, 2026 2:15 AM - 3:45 AM UTC
Wed. Dec 2, 2026 2:15 AM - 3:45 AM UTC
Room 10 (Conference Center 4F 413)
Chairs: Yasufumi Katanasaka (University of Shizuoka), Hideki Tatsukawa (Nagoya University)
Presentation Time: 10 minutes (8 minutes for the presentation, 1 minute 30 seconds for discussion, and 30 seconds for transition)
[2AT2-10-01(2P-0547)]PIP3 Levels Resolve the Paradox of Insulin Resistance: Suppression of Hepatic Gluconeogenesis Requires a High-Threshold PIP3 Signal and Dual AKT Phosphorylation
○Shogo Yanai1, Katsuya Yuguchi1, Hiroaki Kajiho1, Junko Sasaki1, Takehiko Sasaki1 (1. Science Tokyo)
[2AT2-10-02(2P-0549)]Structural and thermodynamic basis of nucleotide recognition by the molecular sensor CtBP2 in obesity pathogenesis
○Kenta Kainoh1,2, Daichi Yamazaki1, Ayumi Nakata1, Yuto Kobari1, Nao Soma1, Teppei Nishino1, Wanpei Chen1, Takafumi Miyamoto1, Motohiro Sekiya1, Toshiya Senda2, Ryuichi Kato2 (1. Univ. of Tsukuba, 2. KEK)
[2AT2-10-03(3P-0567)]Mitochondrial compensatory response mechanisms against aging
○Tsuyoshi Kadomatsu1, Michio Sato1, Sumio Ohtsuki1, Yuichi Oike1 (1. Grad. Sch. Med. Sci., Kumamoto Univ.)
[2AT2-10-04(2P-0505)]Copper metabolism is enhanced after B cell activation and promotes plasma cell differentiation
○Takeshi Kurasawa1, Akihiko Muto1, Kyoko Ochiai1, Mitsuyo Matsumoto2, Ari Itoh-Nakadai3, Hiroki Taguchi4,5, Yoshiro Saito4, Kazutaka Murayama6, Kazuhiko Igarashi1 (1. Dept. Biochem., Tohoku Univ. Grad. Sch. Med., 2. NICHe., Tohoku Univ., 3. Dept. Hygiene and Public health., Nippon Medical School. Grad. Sch. Med., 4. Laboratory of Molecular Biology and Metabolism, Tohoku Univ. Grad. Sch. Pharmaceutical Sciences, 5. Environmental Medicine and Molecular Toxicology, Tohoku Univ. Grad. Sch. Med., 6. Dept. Biomedical Supramolecular Analysis., Tohoku Univ. Grad. Sch. Biomedical engineering)
[2AT2-10-05(2P-0507)]Function of supersulfides in naïve CD4 T-cell activation
○Eunkyu Sung1,2, Tadahisa Numakura3, Mitsuhiro Yamada3, Tomoaki Ida4, Rei Nakano5, Masanobu Morita6, Shunichi Tayama7, Madoka Kawaguchi1, Kenji Chamoto8, Naoto Ishii7, Takaaki Akaike4, Hozumi Motohashi1,2 (1. Department of Medical Chemistry, Tohoku University Graduate School of Medicine, 2. Department of Gene Expression Regulation, IDAC, Tohoku University, 3. Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, 4. Department of Redox Molecular Medicine, Tohoku University Graduate School of Medicine, 5. RIKEN Center for Integrative Medical Sciences, 6. Environmental Medicine and Molecular Toxicology, Tohoku University Graduate Medicine, 7. Depertment of Microbiology and Immunology, Tohoku University Graduate Medicine, 8. Center for Cancer Immunotherapy and Immunobiology, Kyoto University Graduate Medicine)
[2AT2-10-06(3P-0451)]Iro-C/IRX creates anti-cancerized epithelial field against IL-6-dependent tumorigenesis
○Tomonori Nakanishi1, Masato Enomoto1,2,3, Tatsushi Igaki1,2 (1. Graduate School of Pharmaceutical Sciences, Kyoto University, 2. Laboratory of Genetics, Graduate School of Biostudies, Kyoto University, 3. Laboratory of Dynamic Biology, Department of Integrative Vascular Biology, Faculty of Medical Sciences, University of Fukui)
[2AT2-10-07(3P-0572)]Development of a nucleic acid prodrug that activates mitochondrial function and its anti-aging effects
○Haruto Maeda1, Takahisa Anada1,2, Michiharu Kawahara1, Rikuto Hikiji1, Masaru Tanaka1,2 (1. Kyushu University, 2. Institute for Materials Chemistry and Engineering)
[2AT2-10-08(2P-0550)]Spermidine Attenuates Acute Inflammatory Responses Following Ischemic Stroke
○Miki Matsunaga1, Naoya Kase2, Masahiro Komeno2, Akihiro Sekiguchi2, Rio Suzuki1, Saki Chujyo2, Mio Hoshiya2, Akari Shino1, Yosuke Harada2, Takeshi Uemura3, Kazuei Igarashi4, Kyohei Higashi2 (1. Grad. Sch. Pharm. Sci., Tokyo Univ. of Science, 2. Fac. Pharm. Sci., Tokyo Univ. of Science, 3. Fac. Pharm. Sci., Josai Univ., 4. Amine Pharma Res. Inst.)
[2AT2-10-09(3P-0455)]Suppression of PAR-bZIP-dependent transcriptional activity in glioblastoma contributes to the development of temozolomide resistance
○Misaki Okamoto1, Yuichiro Kai1, Takuto Inoki1, Tomoaki Yamauchi1, Akito Tsuruta1, Satoru Koyanagi1 (1. Grad. Sch. of Pharm., Kyushu Univ.)
